Early-stage wearable platform
Non-chemical appetite regulation.
We are translating a patented, non-invasive hunger-control method into a scalable wearable and validating appetite regulation with modern measurement.
Pre-commercial. Research and development stage.
The problem
Pharmacological appetite control is effective, but it carries cost, dependency, and access friction. A large segment of the market wants non-chemical options that are consistent and measurable.
Our posture
We are not a program. We are not a supplement. We are building infrastructure: a device-led, data-generating system for appetite regulation.
The insight
A proprietary stimulation approach has been refined through decades of real-world practice, applied at scale, and protected by issued intellectual property. The method has been used across more than 400,000 client applications over 30+ years of nationwide practice. The opportunity now is translation: engineering the signal into repeatable hardware parameters and validating outcomes with modern study design.
Patented foundation. Exclusively licensed to Satiogenix.
What we are building
- Passive wearable designed for consistent application, minimal user effort.
- Non-invasive protocol translated into engineered parameters.
- Validation-first roadmap focused on appetite and craving metrics before longer-term endpoints.
- Data loop to improve protocol, adherence design, and personalization over time.
Engagement
We engage selectively with domain experts, strategic collaborators, and early supporters to advance translation, validation, and regulatory readiness.
- Wearable and medical device architecture
- Obesity medicine and neuroendocrine expertise
- Clinical study design and regulatory professionals
Engagements are selective, time-boxed, and outcome-oriented. Equity-based when appropriate.
With qualified counterparts, we share validation plans, milestones, and an IP and licensing overview under appropriate confidentiality.
Contact for engagementContact
For engagement, diligence, or introductions: hello@satiogenix.com
Satiogenix™ is an early-stage R&D company. Nothing on this site is medical advice or a consumer offering.